Cargando…
Access to New Cytotoxic Triterpene and Steroidal Acid-TEMPO Conjugates by Ugi Multicomponent-Reactions †
Multicomponent reactions, especially the Ugi-four component reaction (U-4CR), provide powerful protocols to efficiently access compounds having potent biological and pharmacological effects. Thus, a diverse library of betulinic acid (BA), fusidic acid (FA), cholic acid (CA) conjugates with TEMPO (ni...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268079/ https://www.ncbi.nlm.nih.gov/pubmed/34281176 http://dx.doi.org/10.3390/ijms22137125 |
_version_ | 1783720278176563200 |
---|---|
author | Sultani, Haider N. Morgan, Ibrahim Hussain, Hidayat Roos, Andreas H. Haeri, Haleh H. Kaluđerović, Goran N. Hinderberger, Dariush Westermann, Bernhard |
author_facet | Sultani, Haider N. Morgan, Ibrahim Hussain, Hidayat Roos, Andreas H. Haeri, Haleh H. Kaluđerović, Goran N. Hinderberger, Dariush Westermann, Bernhard |
author_sort | Sultani, Haider N. |
collection | PubMed |
description | Multicomponent reactions, especially the Ugi-four component reaction (U-4CR), provide powerful protocols to efficiently access compounds having potent biological and pharmacological effects. Thus, a diverse library of betulinic acid (BA), fusidic acid (FA), cholic acid (CA) conjugates with TEMPO (nitroxide) have been prepared using this approach, which also makes them applicable in electron paramagnetic resonance (EPR) spectroscopy. Moreover, convertible amide modified spin-labelled fusidic acid derivatives were selected for post-Ugi modification utilizing a wide range of reaction conditions which kept the paramagnetic center intact. The nitroxide labelled betulinic acid analogue 6 possesses cytotoxic effects towards two investigated cell lines: prostate cancer PC3 (IC(50) 7.4 ± 0.7 μM) and colon cancer HT29 (IC(50) 9.0 ± 0.4 μM). Notably, spin-labelled fusidic acid derivative 8 acts strongly against these two cancer cell lines (PC3: IC(50) 6.0 ± 1.1 μM; HT29: IC(50) 7.4 ± 0.6 μM). Additionally, another fusidic acid analogue 9 was also found to be active towards HT29 with IC(50) 7.0 ± 0.3 μM (CV). Studies on the mode of action revealed that compound 8 increased the level of caspase-3 significantly which clearly indicates induction of apoptosis by activation of the caspase pathway. Furthermore, the exclusive mitochondria targeting of compound 18 was successfully achieved, since mitochondria are the major source of ROS generation. |
format | Online Article Text |
id | pubmed-8268079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82680792021-07-10 Access to New Cytotoxic Triterpene and Steroidal Acid-TEMPO Conjugates by Ugi Multicomponent-Reactions † Sultani, Haider N. Morgan, Ibrahim Hussain, Hidayat Roos, Andreas H. Haeri, Haleh H. Kaluđerović, Goran N. Hinderberger, Dariush Westermann, Bernhard Int J Mol Sci Article Multicomponent reactions, especially the Ugi-four component reaction (U-4CR), provide powerful protocols to efficiently access compounds having potent biological and pharmacological effects. Thus, a diverse library of betulinic acid (BA), fusidic acid (FA), cholic acid (CA) conjugates with TEMPO (nitroxide) have been prepared using this approach, which also makes them applicable in electron paramagnetic resonance (EPR) spectroscopy. Moreover, convertible amide modified spin-labelled fusidic acid derivatives were selected for post-Ugi modification utilizing a wide range of reaction conditions which kept the paramagnetic center intact. The nitroxide labelled betulinic acid analogue 6 possesses cytotoxic effects towards two investigated cell lines: prostate cancer PC3 (IC(50) 7.4 ± 0.7 μM) and colon cancer HT29 (IC(50) 9.0 ± 0.4 μM). Notably, spin-labelled fusidic acid derivative 8 acts strongly against these two cancer cell lines (PC3: IC(50) 6.0 ± 1.1 μM; HT29: IC(50) 7.4 ± 0.6 μM). Additionally, another fusidic acid analogue 9 was also found to be active towards HT29 with IC(50) 7.0 ± 0.3 μM (CV). Studies on the mode of action revealed that compound 8 increased the level of caspase-3 significantly which clearly indicates induction of apoptosis by activation of the caspase pathway. Furthermore, the exclusive mitochondria targeting of compound 18 was successfully achieved, since mitochondria are the major source of ROS generation. MDPI 2021-07-01 /pmc/articles/PMC8268079/ /pubmed/34281176 http://dx.doi.org/10.3390/ijms22137125 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sultani, Haider N. Morgan, Ibrahim Hussain, Hidayat Roos, Andreas H. Haeri, Haleh H. Kaluđerović, Goran N. Hinderberger, Dariush Westermann, Bernhard Access to New Cytotoxic Triterpene and Steroidal Acid-TEMPO Conjugates by Ugi Multicomponent-Reactions † |
title | Access to New Cytotoxic Triterpene and Steroidal Acid-TEMPO Conjugates by Ugi Multicomponent-Reactions † |
title_full | Access to New Cytotoxic Triterpene and Steroidal Acid-TEMPO Conjugates by Ugi Multicomponent-Reactions † |
title_fullStr | Access to New Cytotoxic Triterpene and Steroidal Acid-TEMPO Conjugates by Ugi Multicomponent-Reactions † |
title_full_unstemmed | Access to New Cytotoxic Triterpene and Steroidal Acid-TEMPO Conjugates by Ugi Multicomponent-Reactions † |
title_short | Access to New Cytotoxic Triterpene and Steroidal Acid-TEMPO Conjugates by Ugi Multicomponent-Reactions † |
title_sort | access to new cytotoxic triterpene and steroidal acid-tempo conjugates by ugi multicomponent-reactions † |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268079/ https://www.ncbi.nlm.nih.gov/pubmed/34281176 http://dx.doi.org/10.3390/ijms22137125 |
work_keys_str_mv | AT sultanihaidern accesstonewcytotoxictriterpeneandsteroidalacidtempoconjugatesbyugimulticomponentreactions AT morganibrahim accesstonewcytotoxictriterpeneandsteroidalacidtempoconjugatesbyugimulticomponentreactions AT hussainhidayat accesstonewcytotoxictriterpeneandsteroidalacidtempoconjugatesbyugimulticomponentreactions AT roosandreash accesstonewcytotoxictriterpeneandsteroidalacidtempoconjugatesbyugimulticomponentreactions AT haerihalehh accesstonewcytotoxictriterpeneandsteroidalacidtempoconjugatesbyugimulticomponentreactions AT kaluđerovicgorann accesstonewcytotoxictriterpeneandsteroidalacidtempoconjugatesbyugimulticomponentreactions AT hinderbergerdariush accesstonewcytotoxictriterpeneandsteroidalacidtempoconjugatesbyugimulticomponentreactions AT westermannbernhard accesstonewcytotoxictriterpeneandsteroidalacidtempoconjugatesbyugimulticomponentreactions |